Edgewise Therapeutics, Inc. (EWTX) Net income 2020–2025
Edgewise Therapeutics, Inc. (EWTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$167.8MFY2025 · since FY2020: -$17.1M → -$167.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$167.8M | -25.4% |
| FY2024 | -$133.8M | -33.6% |
| FY2023 | -$100.2M | -48.1% |
| FY2022 | -$67.6M | -58.0% |
| FY2021 | -$42.8M | -150.0% |
| FY2020 | -$17.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice